Gastroduodenal tolerability of lumiracoxib vs. placebo and naproxen: a pilot endoscopic study in healthy male subjects
- 1 September 2003
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 18 (5) , 533-541
- https://doi.org/10.1046/j.1365-2036.2003.01691.x
Abstract
Background : Lumiracoxib (Prexige®) is a cyclooxygenase‐2 (COX‐2) selective inhibitor. Aim : To compare the gastroduodenal tolerability of lumiracoxib with placebo and naproxen in a randomized, paral...Keywords
This publication has 35 references indexed in Scilit:
- Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year studyAnnals of the Rheumatic Diseases, 2002
- Chronic shoulder pain in the community: a syndrome of disability or distress?Annals of the Rheumatic Diseases, 2002
- Phase transitions sequence in pyrochlore Cd2Nb2O7 studied by IR reflectivityZeitschrift für Physik B Condensed Matter, 2001
- EditorialZeitschrift für Physik B Condensed Matter, 2001
- Tolerability profiles of rofecoxib (Vioxx®) and Arthrotec®: A comparison of six weeks treatment in patients with osteoarthritisScandinavian Journal of Rheumatology, 2001
- A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisGastroenterology, 1999
- Gastrointestinal tolerability of lornoxicam compared to that of naproxen in healthy male volunteersAlimentary Pharmacology & Therapeutics, 1996
- EVALUATION OF THE EFFICACY AND COMPARATIVE EFFECTS ON GASTRIC AND DUODENAL MUCOSA OF ETODOLAC AND NAPROXEN IN PATIENTS WITH RHEUMATOID ARTHRITIS USING ENDOSCOPYRheumatology, 1989
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosaGastrointestinal Endoscopy, 1975